Prestige Consumer Healthcare
282 hedge funds and large institutions have $3.16B invested in Prestige Consumer Healthcare in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 102 increasing their positions, 114 reducing their positions, and 30 closing their positions.
833% more call options, than puts
Call options by funds: $56K | Put options by funds: $6K
9% more capital invested
Capital invested by funds: $2.91B → $3.16B (+$248M)
8.38% more ownership
Funds ownership: 93.45% → 101.83% (+8.4%)
2% less funds holding
Funds holding: 287 → 282 (-5)
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
11% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 114
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$75.9M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$48.8M |
| 3 |
Goldman Sachs
New York
|
+$25.7M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$21.3M |
| 5 |
ClearBridge Investments
New York
|
+$15.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.3M |
| 2 |
BlackRock
New York
|
-$18.2M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
-$16.9M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$15.4M |
| 5 |
BC
Burney Company
Reston,
Virginia
|
-$13.3M |
PBH Hedge Fund Activity: Q1 2023 in Review
282 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2023, worth a combined $3.16B — up 8.5% from $2.91B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PBH and 27 opened new positions — a net loss of 3 holders — while 114 trimmed existing stakes and 102 added.
The largest buyer was Westwood Holdings Group, adding an estimated $75.9M. The largest seller was Wellington Management Group, exiting entirely with an estimated $18.3M sold.
- 282 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2023, down from 287 in Q4 2022.
- Funds reported $3.16B of Prestige Consumer Healthcare stock for Q1 2023, up 8.5% quarter-over-quarter.
- 27 funds opened new Prestige Consumer Healthcare positions in Q1 2023 and 30 closed out, a net change of -3 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2023 was Westwood Holdings Group, an estimated $75.9M added.
- The largest Prestige Consumer Healthcare seller in Q1 2023 was Wellington Management Group, an estimated $18.3M sold.
Based on aggregated 13F filings for Q1 2023.